These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7950982

  • 21. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ, Liu MR, Woods JH, Medzihradsky F.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
    [Abstract] [Full Text] [Related]

  • 22. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
    Merkouris M, Dragatsis I, Megaritis G, Konidakis G, Zioudrou C, Milligan G, Georgoussi Z.
    Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
    [Abstract] [Full Text] [Related]

  • 23. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
    Liao S, Alfaro-Lopez J, Shenderovich MD, Hosohata K, Lin J, Li X, Stropova D, Davis P, Jernigan KA, Porreca F, Yamamura HI, Hruby VJ.
    J Med Chem; 1998 Nov 19; 41(24):4767-76. PubMed ID: 9822547
    [Abstract] [Full Text] [Related]

  • 24. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K, Rónai AZ.
    J Pharmacol Exp Ther; 2001 Jun 19; 297(3):1010-5. PubMed ID: 11356923
    [Abstract] [Full Text] [Related]

  • 25. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ, Santoro G, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1996 Jun 19; 277(3):1284-91. PubMed ID: 8667189
    [Abstract] [Full Text] [Related]

  • 26. Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies.
    Kitchen I, Leslie FM, Kelly M, Barnes R, Crook TJ, Hill RG, Borsodi A, Toth G, Melchiorri P, Negri L.
    J Pharmacol Exp Ther; 1995 Dec 19; 275(3):1597-607. PubMed ID: 8531134
    [Abstract] [Full Text] [Related]

  • 27. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain.
    Sim-Selley LJ, Xiao R, Childers SR.
    Synapse; 2000 Mar 15; 35(4):256-64. PubMed ID: 10657035
    [Abstract] [Full Text] [Related]

  • 28. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y, Zhang X, Homma K, Rice KC, Calderon SN, Rothman RB, Yamamura HI, Davis P, Flippen-Anderson JL, Xu H, Becketts K, Foltz EJ, Porreca F.
    J Med Chem; 1997 Aug 29; 40(18):2936-47. PubMed ID: 9288176
    [Abstract] [Full Text] [Related]

  • 29. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 29; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 30. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Jun 29; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
    Martin TJ, Dworkin SI, Smith JE.
    J Pharmacol Exp Ther; 1993 Oct 29; 267(1):506-14. PubMed ID: 8229781
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of imipramine treatment on delta-opioid receptors of the rat brain cortex and striatum.
    Varona A, Gil J, Saracibar G, Maza JL, Echevarria E, Irazusta J.
    Arzneimittelforschung; 2003 Oct 29; 53(1):21-5. PubMed ID: 12608010
    [Abstract] [Full Text] [Related]

  • 39. Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes.
    Portoghese PS, Sultana M, Nelson WL, Klein P, Takemori AE.
    J Med Chem; 1992 Oct 30; 35(22):4086-91. PubMed ID: 1331455
    [Abstract] [Full Text] [Related]

  • 40. Anomalous binding of DPDPE as a result of batch variability.
    Taylor L, Mansour A, Watson SJ, Akil H.
    NIDA Res Monogr; 1986 Oct 30; 75():201-4. PubMed ID: 2828973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.